IP Library › Assignment 052035/0192
Patent Assignment
Reel/Frame 052035/0192

Assignment of Assignor's Interest

Recorded: 2020-03-06 Pages: 10
Assignors
WARNER, STEVEN L.
Executed: 2020-03-02
SIDDIQUI-JAIN, ADAM
Executed: 2020-02-24
FLYNN, PAUL
Executed: 2020-02-21
Assignee
TOLERO PHARMACEUTICALS, INC.
9300 N. TRAVERSE MOUNTAIN BLVD., LEHI, UTAH, 84043
Covered Property (1)
Formulations Comprising Heterocyclic Protein Kinase Inhibitors
Application: 16/789,342 →
Publication: US 2020/0338076
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger Jul 10, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 053172/0940 →
Change of Name Jul 10, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053184/0718 →
Change of Name Apr 25, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059787/0758 →
Merger Sep 18, 2024
From: SUMITOMO PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA AMERICA, INC.
Reel/Frame 068618/0375 →